Concord Healthcare Group Co., Ltd. (HKG:2453)

Market Cap	1.25B -74.7%
Revenue (ttm)	511.81M +18.4%
Net Income	-285.55M
EPS	-0.38
Shares Out	783.66M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	327,200
Average Volume	508,250
Open	1.550
Previous Close	1.620
Day's Range	1.520 - 1.620
52-Week Range	1.020 - 7.910
Beta	-1.18
RSI	60.83
Earnings Date	Mar 27, 2026

About Concord Healthcare Group

Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People’s Republic of China. It operates through Hospital Business; and Medical Equipment, Software and Related Services segments. The company also offers oncology-related services, including sale and installation of medical equipment and software; management and technical support services to hospitals; and operating lease services. In addition, it engages in leasing of radiotherapy and diagnostic imaging equipm...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2008
• Employees: 573
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2453

Financial Performance

In 2025, Concord Healthcare Group's revenue was 459.92 million, an increase of 18.44% compared to the previous year's 388.31 million. Losses were -256.60 million, -42.11% less than in 2024.

Financial numbers in CNY